Proton Pump Inhibitors May Increase the Risk of HCV Treatment Failure
- Wijarnpreecha K, Chesdachai S, Thongprayoon C, et al. Efficacy and safety of direct-acting antivirals in hepatitis C virus-infected patients taking proton pump inhibitors. Journal of Clinical and Translational Hepatology. 28 Dec 2017; 5(4), 327-34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719190/. Accessed January 17, 2018.